Below are the most recent publications written about "Pruritus" by people in Profiles.
-
Chen J, Bielory L. Comparison of cytokine mediators in type 2 inflammatory conditions on the skin and ocular surface. Curr Opin Allergy Clin Immunol. 2022 10 01; 22(5):319-327.
-
Rashidghamat E, Kadiyirire T, Ayis S, Petrof G, Liu L, Pullabhatla V, Ainali C, Guy A, Aristodemou S, McMillan JR, Ozoemena L, Mee J, Pramanik R, Saxena A, Nuamah R, de Rinaldis E, Serrano S, Maurin C, Martinez-Queipo M, Lwin SM, Ilic D, Martinez A, Dazzi F, Slaper-Cortenbach I, Westinga K, Zeddies S, van den Broek M, Onoufriadis A, Mellerio JE, McGrath JA. Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol. 2020 Aug; 83(2):447-454.
-
Kambhampati S, Bauer KE, Bracci PM, Keenan BP, Behr SC, Gordan JD, Kelley RK. Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series. Cancer. 2019 09 15; 125(18):3234-3241.
-
Madni TD, Nakonezny PA, Imran JB, Clark AT, Cunningham HB, Hoopman JE, Arnoldo BD, Wolf SE, Kenkel JM, Phelan HA. Patient satisfaction after fractional ablation of burn scar with 2940nm wavelength Erbium-Yag laser. Burns. 2018 08; 44(5):1100-1105.
-
Malatack JJ, Doyle D. A Drug Regimen for Progressive Familial Cholestasis Type 2. Pediatrics. 2018 01; 141(1).
-
Gorcey L, Lewin JM, Trufant J, Meehan SA, McLellan BN. Papular eruption associated with palifermin. J Am Acad Dermatol. 2014 Sep; 71(3):e101-2.
-
Ruppert L, Apfelbacher C, Molin S, Bauer A, Mahler V, Schmitt J, Elsner P, Diepgen TL, Weisshaar E. Itching in patients with chronic hand eczema: data from the CARPE registry. Dermatology. 2014; 229(2):146-53.
-
Bielory L, Duttachoudhury S, McMunn A. Bepotastine besilate for the treatment of pruritus. Expert Opin Pharmacother. 2013 Dec; 14(18):2553-69.
-
Lavery MJ, Parish LC. Pediculosis capitis revisited. Skinmed. 2012 Jul-Aug; 10(4):198-201.
-
Smith TR, Goldstein J, Singer R, Pugach N, Silberstein S, Pierce MW. Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system. Headache. 2012 Apr; 52(4):612-24.